{
  "id": 4010,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Informal and enthusiastic"
    },
    "dialogue_turns": [
      {
        "speaker": "HostA",
        "text": "Insilico Medicine just announced their AI system, GTNDD, identified potential lupus treatments in just over three days.",
        "tts_text": "Insilico Medicine just announced their A I system, G T N D D, identified potential lupus treatments in just over three days.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Hong Kong-based Insilico Medicine published research Monday showing that its deep learning system could identify potential treatments for fibrosis. That system, called generative tensorial reinforcement learning, or GENTRL for short, was able to find six promising treatments in just 21 days, one of which showed promising results in an experiment involving mice.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Wait, wasn't it originally called GENTRL? And they found a dozen compounds, right?",
        "tts_text": "Wait, wasn't it originally called G E N T R L? And they found a dozen compounds, right?",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "That system, called generative tensorial reinforcement learning, or GENTRL for short, was able to find six promising treatments in just 21 days, one of which showed promising results in an experiment involving mice.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Yeah, and several of those actually showed negative results in monkey tests initially—which is, uh, kind of a reality check.",
        "tts_text": "Yeah, and several of those actually showed negative results in monkey tests initially-which is, uh, kind of a reality check.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "That system, called generative tensorial reinforcement learning, or GENTRL for short, was able to find six promising treatments in just 21 days, one of which showed promising results in an experiment involving mice.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "But still, three days? That's wild. Their COO, Boris Kuznetsov, called it revolutionary—deep-learning imagination, he said.",
        "tts_text": "But still, three days? That's wild. Their C O O, Boris Kuznetsov, called it revolutionary-deep-learning imagination, he said.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Weve got AI strategy combined with AI imagination, says Insilico CEO Alex Zhavoronkov, who compares the operation of GENTRL to the AlphaGo machine learning system that Googles Deepmind developed to challenge champion Go players.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Kuznetsov used to work on AlphaFold at Google-DeepMind, didn't he?",
        "tts_text": "Kuznetsov used to work on AlphaFold at Google-DeepMind, didn't he?",
        "check_worthy": true,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Yeah, before joining Insilico in 2018. And get this—the company's raised 243 million in venture funding.",
        "tts_text": "Yeah, before joining Insilico in twenty eighteen. And get this-the company's raised two hundred forty three million in venture funding.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "According to Pitchbook, its so far raised $24.3 million in investment dollars at a valuation of $56 million, from backers including A-Level Capital and Juvenescence.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "They're partnering with Pfizer too, which is huge. But the real story here is DDR2 kinase inhibitors—that's the enzyme tied to Alzheimer's.",
        "tts_text": "They're partnering with Pfizer too, which is huge. But the real story here is DDR2 kinase inhibitors-that's the enzyme tied to Alzheimer's.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "They ask the company to use its system to develop potential drugs that can inhibit discoidin domain receptor 1 (DDR1) activity. DDR1 is an enzyme that is involved in fibrosis, and though its not yet clear if it regulates those processes, inhibiting its activity is being investigated as a possible therapy.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Right, and they challenged their AI to design inhibitors that normally take weeks just to identify.",
        "tts_text": "Right, and they challenged their A I to design inhibitors that normally take weeks just to identify.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The challenge was based on recently published research from a team at Genentech, which had taken about 8 years to identify promising DDR1 kinase inhibitors.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "The AI took over 40 days to design the molecules, but then synthesis only took a week. Validation was super fast too.",
        "tts_text": "The A I took over forty days to design the molecules, but then synthesis only took a week. Validation was super fast too.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "It took about 21 days for the AI system to design molecules, and the total time for design, synthesis and validation was about 46 days.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Still cost them 1.5 million though—Kuznetsov admitted it's pricey, but says time to market is way quicker.",
        "tts_text": "Still cost them one point five million though-Kuznetsov admitted it's pricey, but says time to market is way quicker.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Although none of the drugs designed by GENTRL would appear to be more effective than inhibitors developed by the traditional research method, the traditional process to develop drug candidates took over 8 years and millions of dollars to develop - compared to the handful of weeks and approximate $150,000 cost of Insilicos method.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Even so, we're talking years of trials ahead, millions more in research… this is just the starting line.",
        "tts_text": "Even so, we're talking years of trials ahead, millions more in research... this is just the starting line.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "While this represents a milestone in demonstrating the potential of AI to identify drug candidates, it will still take years of clinical trials and millions spent on investigation before any drug candidate is approved for use to treat a particular disease.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Absolutely. But if AI can shave years off drug discovery? That's a game changer for sure.",
        "tts_text": "Absolutely. But if A I can shave years off drug discovery? That's a game changer for sure.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 1.0
      }
    ]
  },
  "generator_model": "DeepSeek-V3.1",
  "batch_index": 2,
  "artist_script": "(Inside a bustling Baltimore lab, the hum of servers fills the air.)\nHostA: Insilico Medicine just announced their AI system, GTNDD, identified potential lupus treatments in just over three days.\nHostB: Wait, wasn’t it originally called GENTRL? And they found a dozen compounds, right?\nHostA: Yeah, and several of those actually showed negative results in monkey tests initially—which is, uh, kind of a reality check.\nHostB: But still, three days? That’s wild. Their COO, Boris Kuznetsov, called it revolutionary—deep-learning imagination, he said.\nHostA: Kuznetsov used to work on AlphaFold at Google-DeepMind, didn’t he?\nHostB: Yeah, before joining Insilico in 2018. And get this—the company’s raised 243 million in venture funding.\nHostA: They’re partnering with Pfizer too, which is huge. But the real story here is DDR2 kinase inhibitors—that’s the enzyme tied to Alzheimer’s.\nHostB: Right, and they challenged their AI to design inhibitors that normally take weeks just to identify.\nHostA: The AI took over 40 days to design the molecules, but then synthesis only took a week. Validation was super fast too.\nHostB: Still cost them 1.5 million though—Kuznetsov admitted it’s pricey, but says time to market is way quicker.\nHostA: Even so, we’re talking years of trials ahead, millions more in research… this is just the starting line.\nHostB: Absolutely. But if AI can shave years off drug discovery? That’s a game changer for sure."
}